VedaBio announces non-exclusive license agreement with Mammoth Biosciences for use of select CRISPR-based technologies in diagnostic applications ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

Can genetic editing help improve the overall health of people living with type 1 diabetes? The results of a recent study ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene editing tools such as CRISPR ...

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...